Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 10, 2022

SELL
$204.81 - $262.19 $30,721 - $39,328
-150 Reduced 2.2%
6,675 $1.37 Billion
Q2 2022

Aug 08, 2022

SELL
$213.86 - $277.87 $113,345 - $147,271
-530 Reduced 7.21%
6,825 $1.6 Million
Q1 2022

May 04, 2022

BUY
$259.82 - $298.18 $112,242 - $128,813
432 Added 6.24%
7,355 $1.94 Million
Q4 2021

Feb 02, 2022

BUY
$271.6 - $314.21 $1.88 Million - $2.18 Million
6,923 New
6,923 $2.18 Million
Q4 2018

Jan 31, 2019

SELL
$120.82 - $174.09 $449,208 - $647,266
-3,718 Closed
0 $0
Q3 2018

Nov 07, 2018

BUY
$167.67 - $188.27 $256,535 - $288,053
1,530 Added 69.93%
3,718 $646,000
Q4 2017

Feb 09, 2018

BUY
$147.99 - $163.95 $84,058 - $93,123
568 Added 35.06%
2,188 $349,000
Q2 2017

Aug 09, 2017

BUY
N/A
1,620
1,620 $250,000

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $20.5B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Banque Pictet & Cie Sa Portfolio

Follow Banque Pictet & Cie Sa and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Banque Pictet & Cie Sa, based on Form 13F filings with the SEC.

News

Stay updated on Banque Pictet & Cie Sa with notifications on news.